News | EP Lab | September 28, 2015

Canadian Researchers Devise Method for Predicting Arrhythmias

Study of cardiac condition could lead to design of better cardiac devices

predicting arrhythmias, mcgill university, alternans patterns

September 28, 2015 — Researchers have discovered how to predict some cardiac arrhythmias several steps before they even occur. It’s a finding that could lead to an improved cardiac device, with equipment designed to detect when arrhythmias are about to occur and then act to prevent them.

The McGill University research team focused on a potentially fatal form of arrhythmia occurring in a condition called the long QT syndrome, which runs in families. Patients who have this heart rhythm disorder can sometimes have heartbeats with an abnormal electrical pattern, called alternans, in which long and short heartbeats alternate with one another.

Once the alternans pattern occurs, it can be easy to detect, but the difficulty lies in figuring out how to predict it. The researchers found the answer by using math.

The researchers took cells from the hearts of embryonic chickens and grew tiny clusters of cells that are able to beat on their own. They administered a drug to induce an abnormal heartbeat while using a camera to record how the heartbeat changed. “This experiment mimics the abnormal heartbeat patterns of patients with arrhythmia”, explained Alvin Shrier, Ph.D., co-author of the study and Hosmer Chair in Physiology.

The team was able to predict when the ball of cells was going to switch from a normal rhythm to these alternans. “There is a transition period,” Shrier explained, “in which the variability of the rhythm increases and the pattern gets messy. Sometime after that transition, the alternans start. One interval is a little bit longer, and the next one is a little shorter, but with time the difference in the intervals increase and the pattern becomes very clear.” Researchers designed a math function describing this messy transition that can be used to predict the alternans.

“If further experiments confirm our results, we can imagine cardiac devices software could use a similar function to predict when a person’s heart is taking the first step towards alternans,” said main author and Ph.D. candidate Thomas Quail. “This means a device could reset the heartbeat much earlier than current ones, avoiding a distressing experience for the patient and potential damage to the heart.”

The research was published in the Proceedings of the National Academy of Sciences (PNAS) in June. Research was supported by the Heart and Stroke Foundation of Canada, the Canadian Institutes of Health Research (CIHR), and the Natural Sciences and Engineering Research Council of Canada (NSERC).

For more information: www.mcgill.ca


Related Content

News | EP Lab

Jan. 28, 2026 — Corify Care has announced a major development in cardiac electrophysiology with the publication of its ...

Home January 29, 2026
Home
News | EP Lab

April 22, 2025 — Orchestra BioMed Holdings, a biomedical company accelerating high-impact technologies to patients ...

Home April 29, 2025
Home
News | EP Lab

April 21, 2025 — Stereotaxis, a provider of surgical robotics for minimally invasive endovascular intervention, will ...

Home April 21, 2025
Home
News | EP Lab

Feb. 12, 2025 — Orchestra BioMed Holdings, a biomedical company accelerating high-impact technologies to patients ...

Home February 14, 2025
Home
News | EP Lab

July 31, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home July 31, 2024
Home
News | EP Lab

July 17, 2024 — BioCardia, Inc., a company focused on cellular and cell-derived therapeutics for the treatment of ...

Home July 17, 2024
Home
News | EP Lab

June 25, 2024 — Heart Hospital of New Mexico at Lovelace Medical Center (HHNM) and GE HealthCare (announced HHNM as the ...

Home June 25, 2024
Home
News | EP Lab

May 30, 2024 — Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention, announced ...

Home May 30, 2024
Home
News | EP Lab

May 21, 2024 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

Home May 21, 2024
Home
News | EP Lab

February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 ...

Home February 02, 2024
Home
Subscribe Now